Sign in

NCT03173729Completed

Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries

Point of Care, Real-time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low and Middle Income Countries

Source: ClinicalTrials.gov · Last updated 4 Apr 2024

Brief summary (registry, in English)

This is a-two phase study. Phase 1 will adapt a 3-metabolite biosensor that identifies patients with colorectal cancer (CRC) and precancerous polyps to Nigerian patients. Phase 2 will pilot test and evaluate the point-of-care (POC) biosensor device in Nigeria.

Status (registry)
Completed
Study type
Observational
Enrollment
926 (actual)
First submitted
23 May 2017
Start date
11 Feb 2017
Primary completion date
31 Dec 2023
Lead sponsor
Obafemi Awolowo University Teaching Hospital
NCT number
NCT03173729

What you commit to

  • Study type: Observational
  • Participants enrolled: 926
  • From 11 Feb 2017 to the primary completion date, 31 Dec 2023
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous diagnosis, treatment, or surgery for any cancer other than CRC
  • Inability to provide a urine sample no fewer than 3 days before colonoscopy

Other illness

  • Diagnosis of or suspected inflammatory bowel disease.

Age

  • Age younger than 40 years with no family history of CRC

Other

  • Patients who are unable to provide written informed consent;
  • Any significant medical comorbidities
  • Inability to fully complete the patient satisfaction survey tool

Who the study is looking for

  • Patients \> 40 years of age with LGI bleeding OR
  • Patients who are high risk due to family history of CRC
    • o Must be at most 10 years younger than when relative presented with CRC (for example, a patient with a relative diagnosed at age 40 with CRC will be eligible after age 30) OR
  • Patients with a diagnosis of stage I-III CRC who have no evidence of disease

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Endoscopy Unit, University College Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Endoscopy Unit, Obafemi Awolowo University Teaching Hospitals
Coordinator of this site? Confirm its status
Ile-IfeNigeriaUnknown status
Endoscopy Unit, University of Ilorin Teaching Hospital
Coordinator of this site? Confirm its status
IlorinNigeriaUnknown status
Ladoke Akintola University Teaching Hospital
Coordinator of this site? Confirm its status
OsogboNigeriaUnknown status
Federal Medical Center
Coordinator of this site? Confirm its status
OwoNigeriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.